Non-small cell lung cancer, adenocarcinoma

C3_NSCLC_ADENO

non-small cell lung carcinoma: A group of at least three distinct histological types of lung cancer, including non-small cell squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. Non-small cell lung carcinomas have a poor response to conventional chemotherapy.

Endpoint definition

FinnGen phenotype data

321302 individuals

diagram downward connector

Apply sex-specific rule None

321302

diagram downward connector
diagram bullet

Check conditions

HLP_C3_NSCLC_ADENO

1130

diagram downward connector
diagram bullet

Filter registries

Cause of death: ICD-10 C34
Cause of death: ICD-9 162
Cause of death: ICD-8 162
Cancer registry: Topography ICD-O-3 C34
Cancer registry: Morphology ICD-O-3 8140
Cancer registry: Behaviour codes 3

1130

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions C.O.D: 10, 8, 9

1130

diagram downward connector

Check minimum number of events None

1130

diagram downward connector

Include endpoints None

1130

diagram downward connector
C3_NSCLC_ADENO

Extra metadata

Level in the ICD hierarchy C
First used in FinnGen datafreeze DF4

Summary Statistics

Key figures

All Female Male
Number of individuals 1086 383 703
Unadjusted prevalence (%) 0.35 0.22 0.52
Mean age at first event (years) 68.86 67.42 69.64

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.36 33.99 [24.73, 46.71] <1e-100 516
15 years 0.02 2.59 [1.78, 3.75] 6.0e-7 36
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: C3_NSCLC_ADENO – Non-small cell lung cancer, adenocarcinoma
GWS hits: 1

Survival analyses between endpoints

Plot

before Non-small cell lung cancer, adenocarcinoma
after Non-small cell lung cancer, adenocarcinoma

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Non-small cell lung cancer, adenocarcinoma